Incyte (INCY) FY2014 results: revenue $511 million, up 44.1% on the year
Incyte Corp. (INCY) reported revenue of $511 million for fiscal 2014, the year ended 31 December 2014, up 44.1% on the year before. Net income was -$48 million, and diluted earnings per share $-0.29. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2015.
Revenue
$511 million
+44.1% on the year
FY2009FY2014
Operating margin
-0.9%
-4.5% a year earlier
FY2009FY2014
Net income
-$48 million
FY2009FY2014
Diluted EPS
-$0.29
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
511
355
297
+44.1%
Cost of revenue
3.0
0.6
0.2
+376.8%
Gross profit
508
354
297
+43.5%
Gross margin
99.4%
99.8%
99.9%
Research and development
348
260
210
+33.4%
Selling, general and administrative
166
110
85.4
+50.7%
Operating income
-4.8
-16.1
1.1
Operating margin
-0.9%
-4.5%
0.4%
Interest expense
46.8
38.7
46.1
+21.2%
Pre-tax income
-48.5
-82.8
-44.1
Income tax
-0.1
0.3
0.2
Net income
-48.5
-83.1
-44.3
Net margin
-9.5%
-23.4%
-14.9%
Diluted EPS
-$0.29
-$0.56
-$0.34
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
26.3
9.2
-94.8
+186.0%
Capital expenditure
27.9
4.3
2.8
+553.3%
Free cash flow
-1.6
4.9
-97.7
Free cash flow margin
-0.3%
1.4%
-32.9%
Depreciation and amortisation
41.4
29.2
30.0
+41.8%
Share-based compensation
62.2
38.4
38.5
+61.9%
Diluted shares, weighted
168m
148m
n/a
+13.2%
Shares outstanding at period end
171m
163m
133m
+4.8%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
-81.6
-193
-175
Debt
841
847
410
-0.7%
Other liabilities
37.2
n/a
95.4
Total liabilities and equity
796
630
330
+26.5%
Fixed assets
81.8
26.8
6.3
+204.6%
Intangible assets
2.0
17.5
n/a
-88.4%
Investments
148
37.6
4.4
+293.8%
Cash and equivalents
452
471
224
-4.1%
Inventory
0.4
0.4
0.3
-11.8%
Other assets
112
75.8
95.4
+47.7%
Total assets
796
630
330
+26.5%
10-K for the year ended 31 December 2014, filed 17 February 2015: the filing.